Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure

被引:25
作者
Filsoufi, Farzan [1 ]
Chikwe, Joanna [1 ]
Castillo, Javier G. [1 ]
Rahmanian, Parwis B. [1 ]
Vassalotti, Joseph [2 ]
Adams, David H. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Cardiothorac Surg, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA
关键词
mortality; prosthesis; renal failure; survival;
D O I
10.1093/ndt/gfn337
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Few previous studies have reported on the outcome of patients with renal failure (RF) undergoing valvular surgery, particularly with regard to choice of valve prosthesis. Methods. We retrospectively analyzed prospectively collected data from 155 patients with RF (mean age 62 +/- 14, 42% female) who underwent left-sided valve surgery from January 1998 to December 2006. Patients were divided into two groups: Group 1 (non-dialysis-dependent renal failure (NDRF); creatinine > 2.5 mg/dl; n = 47, 40%) and Group 2 (renal failure dialysis (DRF); n = 108, 60%). Mechanical valves were implanted in 50 (32%) patients and bioprostheses in 63 (41%). Isolated mitral valve reconstruction was performed in 27% (n = 42) of patients. Outcome measures included hospital mortality, major postoperative complications, length of hospital stay, discharge planning and late survival. Results. The overall hospital mortality was 19.3% (n = 30) and was not different between Groups 1 (23%) and 2 (18%). Ejection fraction, peripheral vascular disease, aortic valve replacement and reoperation were independent predictors of hospital mortality. One- and five-year survival rates were 74.4 +/- 7.8% and 53.1 +/- 10.1% in Group 1 and 75.8 +/- 4.6% and 49.1 +/- 7.1% in Group 2 (P = ns), respectively. According to the type of prostheses, hospital mortality and freedom from reoperation were similar in patients with mechanical and biological valves. Five-year survival rate was 51 +/- 10.7 for biological valves versus 55 +/- 8.4 for mechanical valves (P = ns). Conclusions. Hospital mortality and morbidity remain high in patients with RF undergoing valvular surgery and it is not different in NDRF and DRF patients. This study suggests that the type of valve prosthesis does not appear to have an impact on early and late survival but is limited by sample size. It may be that bioprostheses should be more widely used in patients with RF requiring valve replacement.
引用
收藏
页码:3613 / 3621
页数:9
相关论文
共 20 条
[1]   The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes [J].
Bax, Jeroen J. ;
Bonow, Robert O. ;
Tschoepe, Diethelm ;
Inzucchi, Silvio E. ;
Barrett, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (04) :754-760
[2]   Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].
Bonow, RO ;
Carabello, B ;
de Leon, AC ;
Edmunds, LH ;
Fedderly, BJ ;
Freed, MD ;
Gaasch, WH ;
McKay, CR ;
Nishimura, RA ;
O'Gara, PT ;
O'Rourke, RA ;
Rahimtoola, SH ;
Ritchie, JL ;
Cheitlin, MD ;
Eagle, KA ;
Gardner, TJ ;
Garson, A ;
Gibbons, RJ ;
Russell, RO ;
Ryan, TJ ;
Smith, SC .
CIRCULATION, 1998, 98 (18) :1949-1984
[3]   Valve replacement in patients on chronic renal dialysis: Implications for valve prosthesis selection [J].
Brinkman, WT ;
Williams, WH ;
Guyton, RA ;
Jones, EL ;
Craver, JM .
ANNALS OF THORACIC SURGERY, 2002, 74 (01) :37-42
[4]   Valve replacement surgery in end-stage renal failure: Mechanical prostheses versus bioprostheses [J].
Chan, V ;
Jamieson, WRE ;
Fleisher, AG ;
Denmark, D ;
Chan, F ;
Germann, E .
ANNALS OF THORACIC SURGERY, 2006, 81 (03) :857-862
[5]  
Chan V, 2006, J CARDIAC SURG, V21, P139, DOI 10.1111/j.1540-8191.2006.00194.x
[6]   Risks of coronary artery bypass surgery in dialysis-dependent patients - analysis of the 2001 National Inpatient Sample [J].
Charytan, David M. ;
Kuntz, Richard E. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) :1665-1671
[7]   Cardiac surgery in moderate to end-stage renal failure: Analysis of risk factors [J].
de Peppo, AP ;
Nardi, P ;
De Paulis, R ;
Pellegrino, A ;
Forlani, S ;
Scafuri, A ;
Chiariello, L .
ANNALS OF THORACIC SURGERY, 2002, 74 (02) :378-383
[8]   Cardiac surgery with cardiopulmonary bypass in patients with chronic renal failure [J].
Durmaz, I ;
Büket, S ;
Atay, Y ;
Yagdi, T ;
Özbaran, M ;
Boga, M ;
Alat, I ;
Güzelant, A ;
Basarir, S .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (02) :306-315
[9]   Prediction of operative mortality after valve replacement surgery [J].
Edwards, FH ;
Peterson, ED ;
Coombs, LP ;
DeLong, ER ;
Jamieson, WRE ;
Shroyer, ALW ;
Grover, FL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) :885-892
[10]   A decade of change - Risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute [J].
Ferguson, TB ;
Hammill, BG ;
Peterson, ED ;
DeLong, ER ;
Grover, FL .
ANNALS OF THORACIC SURGERY, 2002, 73 (02) :480-489